caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1750609111

Andrew HunterM.D.

PRACTICEFRANKLIN HOSPITALSee all providers at this practice →
HospitalistValley Stream, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
45
Beneficiaries
—
Total drug cost
$11K
Distinct drugs
3
Brand share
28.9%
Top prescribed drugs
Metoprolol Succinate20 claims
Apixaban13 claims
Amlodipine Besylate12 claims
REFERRAL NETWORK

Where Andrew Hunter's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jay Lee
Diagnostic Radiology · New York, NY
1829
LENOX HILL HOSPITAL1545
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
93.1
Quality
79.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
88.8
Payment adjustment
0.76%
APM Entity
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
290
Unique beneficiaries
—
Total services
634
Distinct HCPCS
4
Medicare payment
$50K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,636 Hospitalist providers in NY — above median (cohort median 462).